Medical group backs health shake up of Australia’s medical drugs giant
New report calls out Melbourne drug giant Medtronic ‘out of step with the needs of our patients’
Medical marijuana advocacy group Medicinal Cannabis Australia has responded to concerns raised about the company by the Victorian government, calling on the Victorian Health Minister David Davis to scrap restrictions on its licensing of medicinal cannabis.
In a statement to Medtronic this morning, MEDCA said the Australian medical cannabis industry needed an end to restrictive licensing regime.
“We believe that the Victorian Health Minister should reverse his previous decision to continue to allow Medtronic to operate within the existing health screening, clinical testing and testing regime to the extent that the company is licensed to do so in our state,” MEDCA said.
The group said “medical marijuana patients who have experienced difficulties accessing their medication due to licensing restrictions should continue to continue to use products approved by the Australian Therapeutic Goods Administration (ATMA) and our research and development activities.”
“The ACCC [Australian Competition and Consumer Commission] has made this issue an urgent one for the Victorian public and it was for that reason that the government consulted on removing the re김해안마strictions.
“We know that Medtronic’s decision to continue their business in Victoria without consultation is out of step with the needs of our patients.”
The Victorian Independent Commission Against Corruption conducted a hearing into Medtronic and its services last week, and has also called for changes to medical cannabis law to allow for a broader discussion on the role medicinal cannabis can play in managing chronic illnesses.
“The Victorian Premier has been calling for changes for a while now on the issue of medical cannabis in Victoria and a number of changes to medicinal cannabis licences and licensing regimes could see the current situation brought 카지노to an end,” MEDCA president Greg Leavers said.
“A review of the medical cannabis licensing regime was commenced by the state government in 2013, but has been suspended due to the Victorian Government’s lack of consultation.”
MEDCA urged the state government to introduce an end to the’medical’ licence restrictions currently in place for Medtronic patients who suffer from chronic conditions.
The statement further stated that the Victorian Government also needs to look at the current approach with respect to the provision of medicinal cannabis by companies who want to sell the product across the state, and whether the government should consider whether Medtronic’s medical cannabis operations a크레이지 슬롯nd practices is in compliance with Australian industry standards.
MEDCA also urges a review of the regulatory framework aroun